Clinical Trials Logo
  1. Home
  2. Schizophrenia
  3. NCT02167724
  4. Details
NCT02167724 Clinical Trial

Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or

Schizophrenia Clinical Trial

— BUCCODOR  

Official title:
Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02167724
Other study ID # DENIS CHS 2014
Secondary ID
Status Completed
Phase N/A
First received June 17, 2014
Last updated March 16, 2017
Start date September 2014
Est. completion date January 2016

Study information
Verified date March 2017
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to know the bucco-dental status of patients with schizophrenia in Côte d'Or.

Participation in this study will last only as long as it takes to:

- carry out a bucco-dental examination: evaluation of dental plaque and calculus

- take a blood sample to assess needs in vitamin C (only for patients included at DIJON CHU and CHS Chartreuse)

- complete a 30-minute questionnaire: clinical data and answers to questions concerning dental hygiene and eating habits.

Recruitment information / eligibility
Status Completed
Enrollment 110
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who have provided consent

- Patients over 18 years of age

- Persons with schizophrenia according to the ICD 10 criteria and followed in hospital (complete or day hospital) in one of the hospitals taking part in the study

Exclusion Criteria:

- Adult under guardianship

- Patient not covered by national health insurance

- Pregnant or breast-feeding women

- Patients not stabilized from a psychiatric viewpoint

- Patients experiencing an acute psychiatric episode

- Impossibility to understand and /or poor understanding of French

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Bucco-dental examination

• Blood sample

• Clinical and social questionnaire

Locations
Country Name City State
France CHS La Chartreuse Dijon
France CHU de DIJON Dijon
France CH Semur-en-Auxois Semur-en-Auxois

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Calculate the DMF index (Decayed, Missing, Filled) Baselines
Secondary Calculate the simplified Oral Health Index (OHI-S) Baselines
Secondary Perception of oral health of patients observed Baselines
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A